CO6801756A2 - Derivas de tieno [2,3-d] pirimidina y su uso para el tratamiento de la arritimia - Google Patents

Derivas de tieno [2,3-d] pirimidina y su uso para el tratamiento de la arritimia

Info

Publication number
CO6801756A2
CO6801756A2 CO13252150A CO13252150A CO6801756A2 CO 6801756 A2 CO6801756 A2 CO 6801756A2 CO 13252150 A CO13252150 A CO 13252150A CO 13252150 A CO13252150 A CO 13252150A CO 6801756 A2 CO6801756 A2 CO 6801756A2
Authority
CO
Colombia
Prior art keywords
thieno
drifts
arrhythmia
pyrimidine
treatment
Prior art date
Application number
CO13252150A
Other languages
English (en)
Spanish (es)
Inventor
Derek Eward John
John Ford
Original Assignee
Xention Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44071904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6801756(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Xention Ltd filed Critical Xention Ltd
Publication of CO6801756A2 publication Critical patent/CO6801756A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CO13252150A 2011-04-01 2013-10-24 Derivas de tieno [2,3-d] pirimidina y su uso para el tratamiento de la arritimia CO6801756A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1105659.5A GB201105659D0 (en) 2011-04-01 2011-04-01 Compounds

Publications (1)

Publication Number Publication Date
CO6801756A2 true CO6801756A2 (es) 2013-11-29

Family

ID=44071904

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13252150A CO6801756A2 (es) 2011-04-01 2013-10-24 Derivas de tieno [2,3-d] pirimidina y su uso para el tratamiento de la arritimia

Country Status (42)

Country Link
US (1) US9249155B2 (enExample)
EP (1) EP2694518B1 (enExample)
JP (1) JP5826374B2 (enExample)
KR (1) KR20140023332A (enExample)
CN (1) CN103492392B (enExample)
AP (1) AP2013007198A0 (enExample)
AR (1) AR088735A1 (enExample)
AU (1) AU2012235882B2 (enExample)
BR (1) BR112013025236A2 (enExample)
CA (1) CA2831493A1 (enExample)
CL (1) CL2013002789A1 (enExample)
CO (1) CO6801756A2 (enExample)
CR (1) CR20130488A (enExample)
CU (1) CU24173B1 (enExample)
CY (1) CY1117025T1 (enExample)
DK (1) DK2694518T3 (enExample)
EA (1) EA201301111A1 (enExample)
EC (1) ECSP13012988A (enExample)
ES (1) ES2558563T3 (enExample)
GB (1) GB201105659D0 (enExample)
GT (1) GT201300225A (enExample)
HR (1) HRP20151340T1 (enExample)
HU (1) HUE028438T2 (enExample)
IL (1) IL228555A0 (enExample)
MA (1) MA35064B1 (enExample)
ME (1) ME02314B (enExample)
MX (1) MX335937B (enExample)
NI (1) NI201300100A (enExample)
PE (1) PE20141021A1 (enExample)
PH (1) PH12013501952A1 (enExample)
PL (1) PL2694518T3 (enExample)
PT (1) PT2694518E (enExample)
RS (1) RS54458B1 (enExample)
RU (1) RU2013148627A (enExample)
SG (1) SG193578A1 (enExample)
SI (1) SI2694518T1 (enExample)
SM (1) SMT201500322B (enExample)
TN (1) TN2013000377A1 (enExample)
TW (1) TWI516265B (enExample)
UA (1) UA110131C2 (enExample)
WO (1) WO2012131379A1 (enExample)
ZA (1) ZA201307085B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2922858A4 (en) * 2012-11-20 2016-06-15 Univ Mcgill THIENOPYRIMIDININHIBITORS OF FARNESYL AND / OR GERANYL GERANYL PYROPHOSPHATE SYNTHASE
AU2016378723B2 (en) 2015-12-22 2021-09-30 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
CN106727587A (zh) * 2016-11-28 2017-05-31 李娜 一种治疗心律失常的药物组合物
MA49458A (fr) 2017-06-21 2020-04-29 SHY Therapeutics LLC Composés interagissant avec la superfamille ras destinés à être utilisés dans le traitement de cancers, de maladies inflammatoires, de rasopathies et de maladies fibrotiques
EP3898609A1 (en) 2018-12-19 2021-10-27 Shy Therapeutics LLC Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH317906A (de) 1953-09-16 1956-12-15 Sandoz Ag Verfahren zur Herstellung von 1-Amino-4-oxyanthrachinonsulfonsäuren
AU521790B2 (en) 1977-05-23 1982-04-29 Ici Australia Limited Process for eradication of ticks
ZA782648B (en) 1977-05-23 1979-06-27 Ici Australia Ltd The prevention,control or eradication of infestations of ixodid ticks
DD226893A1 (de) 1981-12-15 1985-09-04 Ralf Boehm Verfahren zur herstellung von arylaminosubstituierten thieno 2,3-d pyrimidinen
IL112566A (en) 1994-02-10 2000-10-31 Wyeth John & Brother Ltd Substituted quinolinones and pharmaceutical compositions containing them
IL112569A (en) 1994-02-10 1999-12-22 Wyeth John & Brother Ltd Pharmaceutical compositions comprising cyclohexylamine derivatives certain such novel compounds and their preparation
IL112568A0 (en) 1994-02-10 1995-05-26 Wyeth John & Brother Ltd Substituted quinolines, their preparation and pharmaceutical compositions containing them
IL112567A (en) 1994-02-10 2000-02-29 Wyeth John & Brother Ltd Substituted quinolines their preparation and pharmaceutical compositions containing them
EP0846119B1 (en) 1995-08-17 2002-11-13 Takeda Chemical Industries, Ltd. Thienopyrimidine derivatives, their production and use as endothelin antagonists
US6083986A (en) 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
SK7599A3 (en) 1996-07-26 1999-07-12 Nissan Chemical Ind Ltd Chroman derivatives and pharmaceutical composition containing the same
US5935945A (en) 1996-10-31 1999-08-10 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
US5969017A (en) 1996-10-31 1999-10-19 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
RU2116309C1 (ru) 1997-02-13 1998-07-27 Институт медицинской паразитологии и тропической медицины им.Е.И.Марциновского 4-[(бензо-2,1,3-тиадиазолил-4)амино]-5,6,7,8-тетрагидробензотиено [2,3-d]пиримидин, обладающий противогельминтной активностью при ларвальном альвеолярном эхинококкозе
US6333337B1 (en) 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
JP2002517385A (ja) 1998-06-05 2002-06-18 イカゲン インク． カリウムチャネル阻害剤
WO2000012492A1 (en) 1998-09-01 2000-03-09 Nissan Chemical Industries, Ltd. Benzoxazine derivatives
US6194458B1 (en) 1998-10-30 2001-02-27 Merck & Co., Inc. Benzamide potassium channel inhibitors
DE19929076A1 (de) 1999-06-25 2000-12-28 Aventis Pharma Gmbh Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
CN1167697C (zh) 1999-09-17 2004-09-22 日产化学工业株式会社 苯并吡喃衍生物
EP1214307B1 (en) 1999-09-24 2004-04-07 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
US6531495B1 (en) 1999-10-02 2003-03-11 Aventis Pharma Deutschland Gmbh 2′-Substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them
DE19947457A1 (de) 1999-10-02 2001-04-05 Aventis Pharma Gmbh 2'-Substituierte 1,1'-Biphenyl-2-carbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen
US6677371B1 (en) 1999-10-05 2004-01-13 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
US6887870B1 (en) 1999-10-12 2005-05-03 Bristol-Myers Squibb Company Heterocyclic sodium/proton exchange inhibitors and method
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
AU781365B2 (en) 1999-12-21 2005-05-19 Icagen, Inc. Potassium channel inhibitors
AU2002212969B2 (en) 2000-09-20 2006-07-06 Merck Sharp & Dohme Corp. Isoquinolinone potassium channel inhibitors
DE10054481A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10059418A1 (de) 2000-11-30 2002-06-20 Aventis Pharma Gmbh Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10060807A1 (de) 2000-12-07 2002-06-20 Aventis Pharma Gmbh Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10061876A1 (de) 2000-12-12 2002-06-20 Aventis Pharma Gmbh Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10104802A1 (de) 2001-02-02 2002-08-08 Merck Patent Gmbh Pharmazeutische Formulierungen enthaltend Thienopirimidine und Endothelin-Rezeptor-Antagonisten (1)
HUP0303005A3 (en) 2001-02-02 2005-05-30 Merck Patent Gmbh Pharmaceutical compositions comprising pyrazolo[4,3-d]pyrimidines or thienopyrimidines and endothelin receptor antagonists
TW589305B (en) 2001-02-14 2004-06-01 Nissan Chemical Ind Ltd 4-aminobenzopyran derivatives
DE10121003A1 (de) 2001-04-28 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
DE10121002A1 (de) 2001-04-28 2002-11-14 Aventis Pharma Gmbh Verwendung von Anthranilsäureamiden als Medikament zur Behandlung von Arrhythmien sowie sie enthaltende pharmazeutische Zubereitungen
DE10128331A1 (de) 2001-06-12 2002-12-19 Aventis Pharma Gmbh Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
IL159218A0 (en) 2001-06-25 2004-06-01 Nissan Chemical Ind Ltd Substituted benzopyran derivatives against arrhythmia
TW200307539A (en) 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
GB0315950D0 (en) 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
KR101186678B1 (ko) * 2003-06-11 2012-09-27 젠션 리미티드 포타슘 채널 억제제로서의 티에노피리미딘 유도체
ZA200600197B (en) * 2003-07-02 2007-06-27 Vertex Pharma Pyrimidines useful as modulators of voltage-gated ion channels
JP2007517793A (ja) 2004-01-06 2007-07-05 大正製薬株式会社 環状アミノ基によって置換されたチエノピリミジン及びチエノピリジン誘導体
WO2006004658A2 (en) 2004-06-29 2006-01-12 Amgen Inc. Furanopyrimidines
US7576212B2 (en) 2004-12-09 2009-08-18 Xention Limited Thieno[2,3-B] pyridines as potassium channel inhibitors
JP5173429B2 (ja) 2004-12-09 2013-04-03 ゼンション・リミテッド 化合物
US20080108611A1 (en) 2006-01-19 2008-05-08 Battista Kathleen A Substituted thienopyrimidine kinase inhibitors
WO2007146284A2 (en) * 2006-06-12 2007-12-21 Vertex Pharmaceuticals Incorporated Thienopyrimidines useful as modulators of ion channels
DE102009039893B4 (de) 2009-09-03 2012-03-29 Bundesanstalt für Materialforschung und -Prüfung (BAM) Verwendung eines Brennstoffs in einem selbstunterhaltenden pulsierenden Sauerstoff-Brennstoff-Verbrennungsprozess

Also Published As

Publication number Publication date
US20140206703A1 (en) 2014-07-24
AR088735A1 (es) 2014-07-02
HK1193096A1 (zh) 2014-09-12
BR112013025236A2 (pt) 2019-09-24
SI2694518T1 (sl) 2016-02-29
CY1117025T1 (el) 2017-04-05
HRP20151340T1 (hr) 2016-02-26
MX2013011301A (es) 2014-04-16
SMT201500322B (it) 2016-02-25
CR20130488A (es) 2013-12-06
NZ615621A (en) 2015-01-30
SG193578A1 (en) 2013-10-30
RS54458B1 (sr) 2016-06-30
ME02314B (me) 2016-06-20
PH12013501952A1 (en) 2018-04-11
US9249155B2 (en) 2016-02-02
GT201300225A (es) 2014-12-30
KR20140023332A (ko) 2014-02-26
TWI516265B (zh) 2016-01-11
MA35064B1 (fr) 2014-04-03
HUE028438T2 (en) 2017-02-28
WO2012131379A1 (en) 2012-10-04
CN103492392A (zh) 2014-01-01
AU2012235882B2 (en) 2015-08-06
CL2013002789A1 (es) 2014-07-18
CN103492392B (zh) 2015-11-25
ECSP13012988A (es) 2013-12-31
IL228555A0 (en) 2013-12-31
AP2013007198A0 (en) 2013-10-31
ZA201307085B (en) 2015-04-29
HK1193806A1 (zh) 2014-10-03
CA2831493A1 (en) 2012-10-04
JP5826374B2 (ja) 2015-12-02
MX335937B (es) 2016-01-04
CU20130124A7 (es) 2014-01-29
GB201105659D0 (en) 2011-05-18
EA201301111A1 (ru) 2014-02-28
NI201300100A (es) 2014-01-07
EP2694518A1 (en) 2014-02-12
AU2012235882A1 (en) 2013-05-02
PT2694518E (pt) 2016-02-05
ES2558563T3 (es) 2016-02-05
TW201244720A (en) 2012-11-16
UA110131C2 (ru) 2015-11-25
PL2694518T3 (pl) 2016-03-31
DK2694518T3 (en) 2015-11-09
CU24173B1 (es) 2016-04-25
PE20141021A1 (es) 2014-08-30
RU2013148627A (ru) 2015-05-10
TN2013000377A1 (en) 2015-01-20
EP2694518B1 (en) 2015-10-07
JP2014509637A (ja) 2014-04-21

Similar Documents

Publication Publication Date Title
AP2014007541A0 (en) Substituted annellated pyrimidine and the use thereof
ZA201507874B (en) 2-aminopyrido[4,3-d]pyrimidin-5-one derivatives and their use as wee-1 inhibitors
ZA201506570B (en) 2-phenylimidazo[1,2-a]pyrimidines as imaging agents
AU2012300844A1 (en) Substituted annellated pyrimidine and the use thereof
ZA201204871B (en) Thiazolo[5,4-d]pyrimidines and their use as agrochemicals
BR112012029437A2 (pt) derivados de pirrolo[2,3-b]pirazina-7-carboxamida e seu uso como inibidores de jak e syk
IL243092B (en) New triazolo[d–4,5]pyrimidine histories
EP2751112A4 (en) SUBSTITUTED PYRAZOLO [3,4-D] PYRIMIDINE AND ITS USE
CO6930363A2 (es) Benzilindazoles sustituidos para uso como inhibidores de la quinasa bub1 en el tratamiento de enfermedades hiperproliferativas
IL240877A0 (en) History of triazolo [5,4-d] pyrimidine, their preparation and pharmaceutical preparations containing them
SG11201402197UA (en) [1, 2, 3] triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2
CO6950473A2 (es) Novedosos derivados de purina y su uso en el tratamiento de enfermedades
IL231903A0 (en) 5,7-substituted-imidazo[1,2-c]pyrimidines
ZA201406323B (en) Triazolo[4,5-d]pyrimidine derivatives
ZA201403441B (en) [1,2,3]triazolo[4,5-d]pyrimidine derivatives as agonists of the cannabinoid
CO6801756A2 (es) Derivas de tieno [2,3-d] pirimidina y su uso para el tratamiento de la arritimia
IL238461A0 (en) 1 hindole-3-carboxamide derivatives and their use as p2y12 inhibitors
ZA201402226B (en) 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives, their manufacture and their use as antiviral active substances
CO6811852A2 (es) Uso de 2,3-dihidroimidazo[1,2-c]quinazolinas sustituidas

Legal Events

Date Code Title Description
FG Application granted